Riskpilot← Back to searchSign inGet full accessAntero Medical AB
ABActiveOrg 5566415039Stockbyvägen 5General medical practice activities · NACE 8621Est. 20031 employees
Revenue 2025
SEK 350K
-42% vs 2024
EBITDA margin
-236.0%
-16% vs 2024
Equity ratio
91.1%
Financial strength
Net profit 2025
SEK 3,9M
-10% vs 2024
| Revenue | SEK 350K | -42% |
| EBITDA | SEK -826K | -16% |
| Net profit | SEK 3,9M | -10% |
| Total assets | SEK 42,5M | +11% |
| Equity | SEK 38,7M | +11% |
| Employees | 1 | — |
Legal name
Antero Medical AB
Org number
5566415039
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 mars 2003
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva öppen privat hälso- och sjukvård främst inom det dermatologiska området, och även idka därmed förenlig verksamhet.
Address
Stockbyvägen 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 416 | 697 | 749 | 608 | 350 |
| Staff expenses | — | −24 | −203 | −10 | −111 |
| EBITDA | −349 | −331 | −688 | −714 | −826 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −349 | −331 | −688 | −714 | −826 |
| Net financials | 4 602 | 1 116 | 2 767 | 5 235 | −9 |
| Profit before tax | 5 058 | 1 619 | 2 467 | 4 441 | 5 126 |
| Tax | −137 | −176 | — | −90 | −1 201 |
| Net profit | 4 921 | 1 442 | 2 467 | 4 351 | 3 925 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 32 573 | 33 092 | 34 808 | 38 131 | 42 498 |
| Equity | 26 966 | 28 208 | 30 675 | 34 793 | 38 718 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 1 429 | 1 740 | 2 381 | 1 806 | 1 110 |
| Total debt | 1 429 | 1 740 | 2 381 | 1 806 | 1 110 |
EBITDA margin
-236.0%
This company
15.8%
Market median
-1594% vs market
20212025
Equity ratio
91.1%
This company
38.2%
Market median
+138% vs market
20212025
Return on equity
10.1%
This company
18.4%
Market median
+45% vs market
20212025
Net profit margin
1121.4%
This company
8.1%
Market median
+13744% vs market
20212025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TD Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Antero Medical AB (this company)
Antero Medical Consulting AktiebolagBoard members of Antero Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tekin Deniz | Audit | 0 companies |
| Karin Margareta Frohm Nilsson | Board of Directors | 0 companies |
| Mats Anders Nilsson | Deputy Board Member | 0 companies |